These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Cancers of the large bowel and hepatobiliary tract. d'Entremont TS; Stevenson JP Cancer Chemother Biol Response Modif; 2002; 20():435-62. PubMed ID: 12703219 [No Abstract] [Full Text] [Related]
13. Locoregional therapy for hepatocellular carcinoma. Guimaraes M; Uflacker R Clin Liver Dis; 2011 May; 15(2):395-421, vii-x. PubMed ID: 21689621 [TBL] [Abstract][Full Text] [Related]
14. Endoscopic and percutaneous approaches to the treatment of biliary tract and primary liver tumors: controversies and advances. Shah KN; Clary BM Surg Oncol Clin N Am; 2014 Apr; 23(2):207-30. PubMed ID: 24560107 [TBL] [Abstract][Full Text] [Related]
15. Top advances of the year: Hepatobiliary cancers. Coffman-D'Annibale KL; Greten TF Cancer; 2023 Apr; 129(8):1149-1155. PubMed ID: 36692965 [TBL] [Abstract][Full Text] [Related]
17. Role of Radioembolization for Biliary Tract and Primary Liver Cancer. Taylor AC; Maddirela D; White SB Surg Oncol Clin N Am; 2019 Oct; 28(4):731-743. PubMed ID: 31472916 [TBL] [Abstract][Full Text] [Related]
18. State of the ablation nation: a review of ablative therapies for cure in the treatment of hepatocellular carcinoma. Salati U; Barry A; Chou FY; Ma R; Liu DM Future Oncol; 2017 Jul; 13(16):1437-1448. PubMed ID: 28685607 [TBL] [Abstract][Full Text] [Related]